Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a ...

Infections caused by the most dangerous class of drug-resistant bacteria in the United States surged 69% between 2019 and 2023, and one strain carrying the NDM enzyme rose 461% over the same period.

Trader Joe's tote bags are a hot item, stateside and abroad. Of the many designs featured, one uniquely vintage pattern is ...

The U.S. Food and Drug Administration (FDA) has officially dropped its warning letter and enforcement complaint against Whoop ...

Have you ever wondered why your windows seemingly never look as good as those in pictures you’ve seen published by interior designers? Even if you’re choosing similar or the s ...

Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...

AI is helping scientists search for new medicines much faster than before. But can it really create the right drug formula on ...

Spread the love“`html Overcoming drug addiction is a challenging journey that many individuals face, but thanks to ...

AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese biotech $30 million upfront to jointly discover and develop two kidney disease drug ...

Objective To systematically map and synthesise the scientific literature on substance use patterns among elite athletes, encompassing recreational substances, performance-enhancing drugs (PEDs) and ...

Plus: Anthropic has shut down access to its top models after a US directive. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world ...

Chemist Tim Cernak is using two decades of experience in Big Pharma to try to save Gila monsters, loggerhead sea turtles, and many more creatures. In 2018, after nearly two decades working in Big ...